ARE
Alexandria Real Estate Equities, Inc.$53.27
Hold
Target $67.49
Report: Feb 23, 2026Real Estate • REIT - Office • Asset-Based OperatorSnapshot
Decision-first overview with recommendation, valuation anchor, and current setup.
Company Overview
Research Snapshot
Price History
Pelican View
Current$53.27+26.7%
Rec: HoldConviction: Medium
Entry Target
$51.92
(3% below current)
Fair Value
$67.49
(27% above current)
Stop Loss
$44.10
(17% below current)
Position Size
Starter
Time Horizon
Strategic
Key Metrics
Live Snapshot
Market Data
52 Week High$93.54
52 Week Low$44.10
Avg. 3 Month Volume2.47M
Efficiency
LTM Gross Margin69.5%
LTM EBITDA Margin4.9%
LTM EBIT Margin-39.7%
LTM Operating Margin-30.5%
LTM ROA-3.9%
LTM ROE-8.6%
LTM ROIC-2.4%
LTM ROCE-3.3%
Capital Structure
Market Cap (MM)$8.0B
Enterprise Value (MM)$19.9B
Shares Outstanding173.30M
Total Debt (MM)$12.40B
Cash & Equivalents (MM)$553.75M
LTM Net Debt (MM)$11.85B
LTM Net Debt/EBITDA80.3x
Growth
TTM Rev. Growth-2.9%
Last 3-Yr Rev. CAGR5.3%
Last 3-Yr EBITDA CAGR-55.0%
Last 3-Yr EPS CAGRN/A
Valuation
Street Target Price$58.33
LTM EV/Revenue6.6x
LTM EV/Gross Profit9.5x
LTM EV/EBIT-16.5x
LTM EV/EBITDA134.8x
LTM P/E-5.6x
LTM EV/FCF10.7x
LTM P/FCF4.3x
LTM P/TB0.2x
LTM P/B0.5x
Dividend Yield10.1%
Payout Ratio-55.5%
Executive SummarySituation: Current price is $53.27 versus fair value $67.49 (26.7% expected return), and valuation confidence is stable. Debate: Bull case depends on Completion of $2.9 Billion Disposition Program Management's plan to sell non-core assets and land to residential developers will reduce leverage and provide a clear read-through for the private market value of the remaining portfolio. Bear case centers on Prolonged Life Science Oversupply Excess supply in tertiary markets like South San Francisco could lead to extended vacancy periods and higher free-rent concessions, further impairing same-property NOI. Conclusion: Recommendation is Hold with Starter sizing and Strategic horizon.
Bull Case
The core megacampus portfolio remains highly resilient with 90.9% occupancy and 3% contractual rent escalators. Aggressive CapEx reduction to $450 million has boosted free cash flow to $1.86 billion, providing ample liquidity for debt repayment. Insiders are signaling confidence, with $1.33 million in net purchases over the last 12 months.
Bear Case
Oversupply in key markets like South San Francisco and Cambridge is pressuring same-property NOI, which fell 6% on a cash basis in Q4 2025. The company has a poor track record of hitting EPS guidance (0% hit rate over 5 years), and the -30.5% operating margin indicates that cost savings have yet to offset the loss of income from dispositions.
Key Catalysts
Mid-Term (6-18 months)Impact: High
Completion of $2.9 Billion Disposition Program Management's plan to sell non-core assets and land to residential developers will reduce leve...
Mid-Term (6-18 months)Impact: Moderate
Commencement of 900,000 RSF in Signed Leases The delivery of these signed leases in Q3 2026 will provide a significant boost to NOI and vali...
Long-Term (18+ months)Impact: Moderate
Alexandria is relevant for analysis at this moment because it is trading at a multi-year low and a significant discount to its liquidation v...
Primary Risks
Concern: High
Prolonged Life Science Oversupply Excess supply in tertiary markets like South San Francisco could lead to extended vacancy periods and high...
Concern: Medium
Interest Rate Volatility and Refinancing Risk As an asset-based operator with $12.4 billion in debt, sustained high interest rates could inc...
Concern: Medium
The stewardship verdict is adequate but requires monitoring. The governance structure is strong, with high board independence and a separate...
Recent Activity
2026-02-12SEC Filing (8-K)
-6.25%Alexandria Real Estate Equities announces public offering of senior notes to repay borrowings and for general corporate purposes.
2025-12-03SEC Filing (8-K)
-10.05%Alexandria Real Estate Equities presents investor day 2025 focusing on company reset and path forward.
2025-10-29SEC Filing (8-K)
-6.64%Alexandria Real Estate Equities provides 2026 guidance update and strategic capital allocation priorities.
2025-10-28SEC Filing (8-K)
-19.17%Alexandria Real Estate Equities executes largest life science lease in company history with 466,598 RSF build-to-suit research hub in San Diego
2025-04-29SEC Filing (8-K)
-5.73%Alexandria Real Estate Equities reports Q1 2025 FFO per share of $2.30, down from $2.35 in Q1 2024
Valuation Table
9.8/10Decision Grade
Scenario Range
$60
Bear
$73
Base
$106
Bull
$53